Subscribe To

Price Alert Latest News Economic Calendar News

NRXP / NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond

NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond

Company to Present Corporate and Psychiatry Franchise Update During Webcast, June 27, 2022, at 7:00am ET RADNOR, Pa. , June 23, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals"), a clinical-stage biopharmaceutical company, today announced its interim Chief Executive Officer, Robert Besthof, and other executive leaders will be presenting a virtual update to the company's business via webcast at the H.C. Read More

Demo Live Account See Partner Details

Content Topics

Pharmaceuticals

Leaders

Present

Wainwright

Annual

Mental

Health

Conference

Neuropsychiatry

Psychedelics

Beyond

Stock

NRXP

Posted: Jun 23 2022, 07:45

Author Name: PRNewsWire

NRXP News

By PRNewsWire
October 5, 2023

NRx Pharmaceuticals to Present at 8th Annual Dawson James Conference

RADNOR, Pa. , Oct. 5, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharma

By Zacks Investment Research
October 3, 2023

NRx Pharma (NRXP) to Initiate Clinical Study on NRX-101, Stock Up

NRx Pharma (NRXP) receives FDA clearance to begin clinical development for its lead candidate, NRX-101, to treat chronic pain.

By PRNewsWire
September 18, 2023

NRx Pharmaceuticals to Present at the Sidoti Virtual Small Cap Conference

RADNOR, Pa. , Sept. 18, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biophar

By PRNewsWire
September 7, 2023

NRx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

RADNOR, Pa. , Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biophar

By Seeking Alpha
August 14, 2023

NRX Pharmaceuticals, Inc. (NRXP) Q2 2023 Earnings Call Transcript

NRX Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Matthew Duffy - Chief Busine

By PRNewsWire
August 7, 2023

NRx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 14, 2023

RADNOR, Pa. , Aug. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a late-stage biopharmaceu

By PRNewsWire
June 2, 2023

NRx Pharmaceuticals to Host Corporate and Strategic Update Conference Call on Monday, June 5, 2023

RADNOR, Pa. , June 2, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharma

By Zacks Investment Research
May 31, 2023

All You Need to Know About NRx Pharmaceuticals, Inc. (NRXP) Rating Upgrade to Buy

NRx Pharmaceuticals, Inc. (NRXP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.